SHC - CIK 0001822479
The table below shows Sotera Health Co's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $287.19M | $224.16M | -$147.73M | $277.96M | $281.55M | $120.58M |
| Capital expenditure | $138.02M | $179.07M | $214.97M | $182.38M | $102.16M | $53.51M |
| Investing cash flow | -$135.14M | -$179.00M | -$214.91M | -$181.90M | -$159.83M | -$158.69M |
| Dividends paid | - | - | - | - | $0.00 |
Sotera Health Co reported operating cash flow of $287.19M for fiscal year 2025. That is up 28.1% from $224.16M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from $149.04M (FY 2019) to $287.19M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $0.00 |
| Stock buybacks | - | - | - | $0.00 | $0.00 | $34.00M |
| Financing cash flow | -$100.53M | -$50.56M | $265.96M | $197.76M | -$117.29M | $73.43M |